beta-Adrenergic regulation of cAMP and protein phosphorylation in phospholamban-knockout mouse hearts - PubMed (original) (raw)
beta-Adrenergic regulation of cAMP and protein phosphorylation in phospholamban-knockout mouse hearts
E Kiss et al. Am J Physiol. 1997 Feb.
Abstract
The stimulatory effects of beta-adrenergic agonists reflect increases in intracellular adenosine 3',5'-cyclic monophosphate (cAMP) levels and phosphorylation of key regulatory proteins in the heart. One of these phosphoproteins is phospholamban (PLB) in sarcoplasmic reticulum, and ablation of PLB is associated with attenuation of the contractile responses to beta-adrenergic stimulation in the mouse heart. To determine whether this attenuation of beta-stimulation is due to altered phosphorylation characteristics of the other key cardiac phosphoproteins and/or to compensatory responses occurring in the absence of PLB, PLB-knockout and wild-type hearts were perfused and their protein phosphorylation patterns examined. The beta-adrenergic receptor density, adenylyl cyclase activity, tissue cAMP levels, and the basal phosphoprotein pattern were similar between PLB-knockout and wild-type hearts. Isoproterenol perfusion resulted in similar increases in the tissue cAMP levels and the degree of phosphorylation of troponin I, C protein, and the 21-kDa microsomal protein in wild-type and PLB-knockout hearts. These findings indicate that the attenuation of isoproterenol-mediated increases in contractility of the PLB-knockout hearts is not due to alterations in the beta-adrenergic signal transduction pathway or the degree of phosphorylation of the key cardiac regulatory phosphoproteins in myofibrils and sarcolemma.
Similar articles
- Intracellular mechanisms mediating reversal of beta-adrenergic stimulation in intact beating hearts.
Talosi L, Edes I, Kranias EG. Talosi L, et al. Am J Physiol. 1993 Mar;264(3 Pt 2):H791-7. doi: 10.1152/ajpheart.1993.264.3.H791. Am J Physiol. 1993. PMID: 8384422 - A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta -agonists.
Chu G, Lester JW, Young KB, Luo W, Zhai J, Kranias EG. Chu G, et al. J Biol Chem. 2000 Dec 8;275(49):38938-43. doi: 10.1074/jbc.M004079200. J Biol Chem. 2000. PMID: 10988285 - Functional interplay between dual site phospholambam phosphorylation: insights from genetically altered mouse models.
Chu G, Kranias EG. Chu G, et al. Basic Res Cardiol. 2002;97 Suppl 1:I43-8. doi: 10.1007/s003950200028. Basic Res Cardiol. 2002. PMID: 12479233 Review. - cAMP-mediated signal transduction and sarcoplasmic reticulum function in heart failure.
Movsesian MA. Movsesian MA. Ann N Y Acad Sci. 1998 Sep 16;853:231-9. doi: 10.1111/j.1749-6632.1998.tb08271.x. Ann N Y Acad Sci. 1998. PMID: 10603951 Review.
Cited by
- 32P labeling of protein phosphorylation and metabolite association in the mitochondria matrix.
Aponte AM, Phillips D, Harris RA, Blinova K, French S, Johnson DT, Balaban RS. Aponte AM, et al. Methods Enzymol. 2009;457:63-80. doi: 10.1016/S0076-6879(09)05004-6. Methods Enzymol. 2009. PMID: 19426862 Free PMC article. - Beta-adrenergic receptor signaling in the heart: role of CaMKII.
Grimm M, Brown JH. Grimm M, et al. J Mol Cell Cardiol. 2010 Feb;48(2):322-30. doi: 10.1016/j.yjmcc.2009.10.016. Epub 2009 Oct 31. J Mol Cell Cardiol. 2010. PMID: 19883653 Free PMC article. Review. - Adrenergic regulation of cardiac contractility does not involve phosphorylation of the cardiac ryanodine receptor at serine 2808.
MacDonnell SM, García-Rivas G, Scherman JA, Kubo H, Chen X, Valdivia H, Houser SR. MacDonnell SM, et al. Circ Res. 2008 Apr 25;102(8):e65-72. doi: 10.1161/CIRCRESAHA.108.174722. Epub 2008 Apr 3. Circ Res. 2008. PMID: 18388322 Free PMC article. - S-Nitrosylation of Calcium-Handling Proteins in Cardiac Adrenergic Signaling and Hypertrophy.
Irie T, Sips PY, Kai S, Kida K, Ikeda K, Hirai S, Moazzami K, Jiramongkolchai P, Bloch DB, Doulias PT, Armoundas AA, Kaneki M, Ischiropoulos H, Kranias E, Bloch KD, Stamler JS, Ichinose F. Irie T, et al. Circ Res. 2015 Oct 9;117(9):793-803. doi: 10.1161/CIRCRESAHA.115.307157. Epub 2015 Aug 10. Circ Res. 2015. PMID: 26259881 Free PMC article. - Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy.
Song Q, Schmidt AG, Hahn HS, Carr AN, Frank B, Pater L, Gerst M, Young K, Hoit BD, McConnell BK, Haghighi K, Seidman CE, Seidman JG, Dorn GW 2nd, Kranias EG. Song Q, et al. J Clin Invest. 2003 Mar;111(6):859-67. doi: 10.1172/JCI16738. J Clin Invest. 2003. PMID: 12639992 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases